Home › Myelofibrosis › Connecticut
Myelofibrosis clinical trials in Connecticut
5 studies for Myelofibrosis are looking for participants at sites in Connecticut.
Cities in Connecticut
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Yale University School Of Medicine, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07357727A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Yale School of Medicine, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT04176198Pacritinib Effectiveness in Real-world Settings
- Yale School of Medicine, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07774455Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Yale Cancer Center, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.